GHRSGH Research PLC Ordinary Shares

28.33USDMkt Cap: 1.94B $P/E:

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable…

Key Statistics

Company
Market Cap1.94B $
Enterprise Value1.60B $
Revenue (TTM)
Gross Profit
Net Income (TTM)-48.26M $
Revenue/Share
Last Price28.33 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-15.50
PEG
EV/EBITDA-22.39
EV/Revenue
P/S
P/B5.48
EPS (TTM)-0.99
EPS (Forward)-1.85
52W Range
28.0525% of range29.15
52W High29.15 USD
52W Low28.05 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-17.25%
ROA-16.74%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-43.55M $
CapEx (TTM)121.00K $
FCF Margin
FCF Yield-1.88%
Net Debt-362.29M $
Net Debt/EBITDA5.08
Balance Sheet
Debt/Equity0.00
Current Ratio28.70
Quick Ratio28.21
Book Value/Sh5.237 USD
Cash/Share5.283 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.89 USD
Upside (mean)+51.4%
Target Range38.00 USD65.00 USD
$38.00+51.4% to mean$65.00
# Analysts9
Ownership
Shares Out.68.64M
Float29.63M
Insiders24.20%
Institutions75.36%
Short Interest
Short Ratio9.2d
Short % Float9.40%
Short % Out.3.69%
Shares Short2.53M
Short (prev mo.)1.94M
Technical
SMA 5026.66 (+6.3%)
SMA 20018.97 (+49.3%)
Beta1.29
S&P 52W Chg21.00%
Avg Vol (30d)139.23K
Avg Vol (10d)420.81K
Technical Indicators
RSI (14)49.1
MACD0.5761
MACD Signal0.8111
MACD Hist.-0.2350
BB Upper30.82 USD
BB Middle29.03 USD
BB Lower27.23 USD
BB Width12.37%
ATR (14)1.484 USD
Vol Ratio (20d)0.40x